Abstract
Objectives Neuropsychiatric symptoms (NPS) are known to increase the risk of cognitive decline in aging. Several studies have investigated the brain substrates of these symptoms, reporting a broad involvement of the limbic regions.
Participants Using the Alzheimer’s Disease Neuroimaging Initiative database, we investigated 223 participants with normal cognition, 367 with mild cognitive impairment (MCI) and 175 with Alzheimer’s disease (AD).
Measurements Neuropsychiatric symptoms were assessed with the Neuropsychiatric Inventory and MRIs were processed with FreeSurfer. We used a general linear model (FreeSurfer) and multivariate analysis of covariance (IBM SPSS software) to establish the associations between the severity of neuropsychiatric symptoms and morphometry in cortical and subcortical structures in each clinical group.
Results The results outlined significant associations between cortical and subcortical structures and neuropsychiatric symptoms. In cognitively normal participants, only a positive association between nighttime behaviors and bilateral caudate nuclei volumes was found. In patients with MCI, agitation, depression, apathy and nighttime behaviors were respectively negatively associated with (i) left precentral and inferior frontal and inferior parietal volumes; (ii) left fusiform volume and area; (iii) right precentral thickness, left frontopolar area and bilateral ventral diencephalon volumes; (iv) right lingual thickness, whereas depression and nighttime behaviors were also respectively positively associated with right ventral diencephalon volume; and left temporal volume and area. In patients with Alzheimer’s disease, broader association were outlined between NPS severity and cortical structures notably agitation, apathy, irritability and nighttime behaviors outlined respectively positive associations with : (i) volumes in the right temporal regions and with surface area in the frontal region; (ii) the cortical thickness of the right pericalcarine region; (iii) volumes in the frontal, temporal and parietal regions; (iv) volume of the right cuneus region; whereas depression and apathy were also respectively negatively associated with the cortical thickness of the left parietal superior region; and cortical volume and area of the parietal regions.
Conclusions These results showed that NPS have broad association patterns with associative brain structures and few associations with limbic structures. These associations were also dependent on the clinical stage of cognitive impairment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
L. Ronat reports having received a doctoral research scholarship from the IUGM Foundation and a merit scholarship from the Faculty of Medicine of the University of Montreal. A. Hanganu has received funding from the IUGM Foundation, Parkinson Quebec, Parkinson Canada, FRQS, Lemaire Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee approval and individual patient consents were received by the corresponding registration sites according to Alzheimers Disease Neuroimaging Initiative rules (http://adni.loni.usc.edu/methods/documents/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Alzheimer’s Disease Neuroimaging Initiative
# Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
Data Availability
All data are available on the Alzheimers Disease Neuroimaging Initiative websites upon demand (http://adni.loni.usc.edu/data-samples/access-data/).
Abbreviations
- ADNI
- Alzheimer’s Disease Neuroimaging Initiative
- CN
- Cognitively Normal
- GLM
- General Linear Model
- MMSE
- MiniMental State Examination
- NPI
- Neuropsychiatric Inventory
- NPS
- Neuropsychiatric Symptoms
- WAIS
- Wechsler Adult Intelligence Scale.